SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 51 filers reported holding SIERRA ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,224,000 | +43.0% | 1,764,889 | 0.0% | 0.18% | +44.1% |
| Q1 2018 | $3,653,000 | -44.4% | 1,764,889 | +0.2% | 0.13% | -51.0% |
| Q4 2017 | $6,569,000 | +51.4% | 1,761,092 | -37.1% | 0.26% | +32.8% |
| Q3 2017 | $4,340,000 | +6.1% | 2,800,000 | -19.9% | 0.20% | -10.6% |
| Q2 2017 | $4,090,000 | -46.2% | 3,495,734 | -29.7% | 0.22% | -25.6% |
| Q1 2017 | $7,608,000 | – | 4,972,319 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
| Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
| Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
| Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
| Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
| 683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
| PA Capital LLC | 138,082 | $236,000 | 0.25% |
| ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |